Macugen Receives FDA's Broad Approval For All Wet AMD Types Dec. 21, 2004 By Aaron Lorenzo No Comments The FDA authorized the first anti-angiogenic treatment for ophthalmology, Macugen, which received approval for the treatment of neovascular (wet) age-related macular degeneration.(BioWorld Today)Read More
Antimicrobial Dermatology Deal Could Be Worth $14M To Ansata Dec. 16, 2004 By Aaron Lorenzo No Comments
Antimicrobial Dermatology Deal Could Be Worth $14M To Ansata Dec. 16, 2004 By Aaron Lorenzo No Comments
Inex Cuts Nearly Two-Thirds Of Staff, Plans New Marqibo Trial Dec. 15, 2004 By Aaron Lorenzo No Comments
Inex Cuts Nearly Two-Thirds Of Staff, Plans New Marqibo Trial Dec. 15, 2004 By Aaron Lorenzo No Comments
